Trials / Completed
CompletedNCT00402337
Dose-range-finding, Phase 2 Trial of Oral Linaclotide Acetate Administered to Patients With Chronic Constipation
A Randomized, Multicenter, Double-blind, Placebo-controlled, Dose-range-finding, Parallel-group, Phase 2 Trial of Oral Linaclotide Acetate Administered to Patients With Chronic Constipation
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 310 (actual)
- Sponsor
- Ironwood Pharmaceuticals, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The primary purpose of this study is to evaluate the efficacy and safety of administration of linaclotide acetate in patients with chronic constipation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | linaclotide acetate | oral, once daily. |
| DRUG | Matching placebo | oral, once daily |
Timeline
- Start date
- 2006-11-01
- Primary completion
- 2007-12-01
- Completion
- 2008-02-01
- First posted
- 2006-11-22
- Last updated
- 2013-03-05
- Results posted
- 2013-03-05
Locations
60 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00402337. Inclusion in this directory is not an endorsement.